Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Feb;75(2):228–233.

Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.

J R Murphy 1, S S Wasserman 1, S Baqar 1, L Schlesinger 1, C Ferreccio 1, A A Lindberg 1, M M Levine 1
PMCID: PMC1542130  PMID: 2702777

Abstract

Experiments were performed in Baltimore, Maryland and in Santiago, Chile, to determine the level of Salmonella typhi antigen-driven in vitro lymphocyte replication response which signifies specific acquired immunity to this bacterium and to determine the best method of data analysis and form of data presentation. Lymphocyte replication was measured as incorporation of 3H-thymidine into desoxyribonucleic acid. Data (ct/min/culture) were analyzed in raw form and following log transformation, by non-parametric and parametric statistical procedures. A preference was developed for log-transformed data and discriminant analysis. Discriminant analysis of log-transformed data revealed 3H-thymidine incorporation rates greater than 3,433 for particulate S. typhi, Ty2 antigen stimulated cultures signified acquired immunity at a sensitivity and specificity of 82.7; for soluble S. typhi O polysaccharide antigen-stimulated cultures, ct/min/culture values of greater than 1,237 signified immunity (sensitivity and specificity 70.5%).

Full text

PDF
230

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHCROFT M. T., RITCHIE J. M., NICHOLSON C. C. CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED AND ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES. Am J Hyg. 1964 Mar;79:196–206. doi: 10.1093/oxfordjournals.aje.a120376. [DOI] [PubMed] [Google Scholar]
  2. Clasener H. A. Immunization of man with salmonella vaccine and tetanus-diphtheria vaccine. Dose-response relationship, secondary response, and competition of antigens. J Hyg (Lond) 1967 Dec;65(4):457–466. doi: 10.1017/s002217240004599x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edelman R., Levine M. M. Summary of an international workshop on typhoid fever. Rev Infect Dis. 1986 May-Jun;8(3):329–349. doi: 10.1093/clinids/8.3.329. [DOI] [PubMed] [Google Scholar]
  4. Espersen F., Mogensen H. H., Høiby N., Høj L., Greibe J., Rasmussen S. N., Gaarslev K. Humoral and cellular immunity in typhoid and paratyphoid carrier state, investigated by means of quantitative immunoelectrophoresis and in vitro stimulation of blood lymphocytes. Acta Pathol Microbiol Immunol Scand C. 1982 Dec;90(6):293–299. doi: 10.1111/j.1699-0463.1982.tb01453.x. [DOI] [PubMed] [Google Scholar]
  5. Germanier R., Füer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis. 1975 May;131(5):553–558. doi: 10.1093/infdis/131.5.553. [DOI] [PubMed] [Google Scholar]
  6. Gilman R. H., Hornick R. B., Woodard W. E., DuPont H. L., Snyder M. J., Levine M. M., Libonati J. P. Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis. 1977 Dec;136(6):717–723. doi: 10.1093/infdis/136.6.717. [DOI] [PubMed] [Google Scholar]
  7. Hejfec L. B., Salmin L. V., Lejtman M. Z., Kuz'minova M. L., Vasil'eva A. V., Levina L. A., Bencianova T. G., Pavlova E. A., Antonova A. A. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull World Health Organ. 1966;34(3):321–339. [PMC free article] [PubMed] [Google Scholar]
  8. Levine M. M., Grados O., Gilman R. H., Woodward W. E., Solis-Plaza R., Waldman W. Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg. 1978 Jul;27(4):795–800. doi: 10.4269/ajtmh.1978.27.795. [DOI] [PubMed] [Google Scholar]
  9. Levine M. M., Herrington D., Murphy J. R., Morris J. G., Losonsky G., Tall B., Lindberg A. A., Svenson S., Baqar S., Edwards M. F. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J Clin Invest. 1987 Mar;79(3):888–902. doi: 10.1172/JCI112899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murphy J. R., Baqar S., Muñoz C., Schlesinger L., Ferreccio C., Lindberg A. A., Svenson S., Losonsky G., Koster F., Levine M. M. Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions. J Infect Dis. 1987 Dec;156(6):1005–1009. doi: 10.1093/infdis/156.6.1005. [DOI] [PubMed] [Google Scholar]
  11. Rajagopalan P., Kumar R., Malaviya A. N. A study of humoral and cell-mediated immune response following typhoid vaccination in human volunteers. Clin Exp Immunol. 1982 Feb;47(2):275–282. [PMC free article] [PubMed] [Google Scholar]
  12. Robertsson J. A., Fossum C., Svenson S. B., Lindberg A. A. Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays. Infect Immun. 1982 Aug;37(2):728–736. doi: 10.1128/iai.37.2.728-736.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Taylor D. N., Pollard R. A., Blake P. A. Typhoid in the United States and the risk to the international traveler. J Infect Dis. 1983 Sep;148(3):599–602. doi: 10.1093/infdis/148.3.599. [DOI] [PubMed] [Google Scholar]
  14. Wahdan M. H., Sérié C., Cerisier Y., Sallam S., Germanier R. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. J Infect Dis. 1982 Mar;145(3):292–295. doi: 10.1093/infdis/145.3.292. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES